Markets
S&P 5007,064-0.63%
Nasdaq 10026,479-0.42%
Dow Jones49,149-0.59%
Russell 20002,765-1.00%
EUR/USD1.1744-0.47%
Gold$4749.20-1.19%
WTI$90.42+0.90%
Brent$93.89-1.67%
UST10 YTM4.29%+0.99%
Markets
S&P 5007,064-0.63%
Nasdaq 10026,479-0.42%
Dow Jones49,149-0.59%
Russell 20002,765-1.00%
EUR/USD1.1744-0.47%
Gold$4749.20-1.19%
WTI$90.42+0.90%
Brent$93.89-1.67%
UST10 YTM4.29%+0.99%
Ocular Therapeutix, Inc. Common Stock(OCUL)
NASDAQ-GM: OCUL · Real-Time Price · USD
$9.32-0.00 (0.00%)
Market Cap$2.03B
Revenue (ttm)$51.95M
Net IncomeN/A
EPS$-1.42
Shares Out217.69M
PE RatioN/A
Forward PE-7.42
DividendN/A
Volume3,517,108
Open$9.32
Previous Close$9.32
Day's Range$9.03 - $9.50
52-Week Range$6.23 - $16.44
Beta0.95
Analystsstrong_buy
Price Target$26.00
About OCUL
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthal...